A shadow market for unapproved weight-loss medications is being driven by social media fitness personalities and vendors on communication apps, according to new investigations.
Experimental Drug Gaining Popularity Via Social Media
The experimental drug, which remains in clinical trials, is being advertised by online personalities for its alleged weight-reducing properties. Viewers are encouraged to contact these profiles directly for source information, while also obtaining discount codes.
Active Commerce on Messaging Platforms
Separately, a robust trade exists on Telegram, where groups with thousands of members share comparison photos, injection guides and claims of next-day UK delivery. Sellers market the drug there before directing buyers to other platforms for transactions.
Understanding Retatrutide
This medication is an investigational injectable developed by US drugmaker Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials suggest it could assist patients lose up to 25% of their total weight. Nicknamed the “triple G”, the drug is being promoted digitally as the successor to Ozempic.
Medical Professionals Express Concerns
However, physicians and chemists have warned that the distribution of what remains an unapproved drug in the UK is a cause for concern and could result in individuals administering products of uncertain source.
Some experts said the popularity for retatrutide could be linked to the rising price of approved weight loss treatments such as Mounjaro.
Regulatory Status and Implementation
Selling retatrutide on social media or messaging apps is illegal in the UK, as it is an unlicensed drug that cannot be promoted or distributed for human use under the British medical regulations.
Some content creators try to circumvent the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and distribution can still breach pharmaceutical, advertising, and consumer laws, risking fines, legal action or prison.
Platform Reaction and Content Removal
Based on the social media company, the platform has taken down problematic content and banned related hashtags and query recommendations. The company stated it was dedicated to maintaining the platform secure and allocating resources in strengthening enforcement strategies.
Online Marketplace Activities
Research also discovered communities with up to nine thousand members selling retatrutide using the platform's built-in search feature, which functions like a online catalog. Typing “retatrutide” immediately displays channels with thousands of members, populated with images of slimming results, positive reviews and step-by-step guides for mixing or administering at residence.
After moments of entering one community, a seller shared WhatsApp details, where the majority of transactions take place. The vendor sent an instruction manual and promised delivery within 48 hours. When asked whether the substance was genuine, one seller responded: “You can’t be sure.” Another shared a photo of a supposed testing documentation. Not one asked about body mass, health issues or past usage.
Item Details and Costs
Inside these communities, messages show dark colored packages with postal service labels, claiming to contain new batches. One communication stated: “It took eight of us to load them this morning.”
Customers can select between dry substance containers, prepared at residence with sterile water, or pre-filled pens typically sold at £160 for 20 milligrams. When asked how much time a injector should be used, vendors give conflicting answers varying between a several days to “depends on your body”.
Platform Oversight and Security Actions
A spokesperson for the messaging service said it actively moderated dangerous material on its platform including material that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.
Medical Expert Warnings
“Individuals are administering substances they can’t verify. Although the research behind this drug is valid, these online versions may not include what they claim,” said a pharmacy expert, the head of pharmacy at a pharmacy service.
A medical professional of Asda Online Doctor connected the increase in interest to current price rises for approved slimming drugs such as Mounjaro. “With costs rising, patients are using social media. But fake injections are extremely risky. You cannot know what’s inside or whether the conditions they were produced in was sterile,” she explained.
Her staff has already encountered patients harmed by self-injection from unconfirmed suppliers. “We recognize the disappointment, but purchasing from messaging apps or WhatsApp is gambling with your well-being,” said the doctor. “These materials could be contaminated or improperly measured.”
Producer Statement
A spokesperson from the pharmaceutical company said retatrutide was in third stage research studies and had not been reviewed or approved by any regulatory agency globally. “Consequently at this time no one can sell [it] for personal consumption,” they explained, adding that any product “misleadingly claiming itself as a Lilly experimental product not yet authorized … may expose users to potentially significant health risks”.
